Bio-Path Holdings to Announce Fourth Quarter and Full Year 2018 Financial Results on March 20, 2019
15 mars 2019 16h01 HE
|
Bio-Path Holdings, Inc.
HOUSTON, March 15, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock
14 janv. 2019 22h23 HE
|
Bio-Path Holdings, Inc.
HOUSTON, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to...
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
14 janv. 2019 16h01 HE
|
Bio-Path Holdings, Inc.
HOUSTON, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology...
Bio-Path Holdings to Announce Third Quarter 2018 Financial Results on November 15, 2018
08 nov. 2018 16h01 HE
|
Bio-Path Holdings, Inc.
HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...